Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Streptococcus pneumoniae is a major cause of pneumonia, meningitis, and septicaemia worldwide. Pneumococcal antimicrobial resistance (AMR) has been highlighted by the WHO as an important public health concern, with emerging serotypes showing resistance to multiple antibiotics. Indeed, although the introduction of pneumococcal conjugate vaccines (PCVs) has been associated with an overall decline in pneumococcal AMR, there have been increases in prevalence of potentially disease-causing AMR serotypes not targeted by vaccination. Here, we discuss a variety of evolutionary mechanisms at the host, pathogen, and environmental levels that may contribute to changes in the prevalence of pneumococcal AMR in the post-vaccination era. The relative importance of these factors may vary by population, pneumococcal lineage, geography, and time, leading to the complex relationship between vaccination, antibiotic use, and AMR.

More information Original publication

DOI

10.1016/j.tim.2022.06.001

Type

Journal article

Publication Date

2022-12-01T00:00:00+00:00

Volume

30

Pages

1135 - 1145

Total pages

10

Keywords

Streptococcus pneumoniae, antimicrobial resistance, evolution, vaccination, Humans, Infant, Streptococcus pneumoniae, Pneumococcal Infections, Anti-Bacterial Agents, Drug Resistance, Bacterial, Pneumococcal Vaccines, Vaccination